Endolymphatic sac epithelial cells (ES epithelial cells)

Endolymphatic sac epithelial cells are specialized cells within the inner ear responsible for the homeostasis of endolymph, the fluid filling the membranous labyrinth (StatPearls, 2023). These cells perform critical functions including fluid absorption, ion exchange, and immune defense, utilizing transporters such as pendrin (SLC26A4) and the V-ATPase proton pump (PubMed, PMID: 17113570). Dysfunction or structural changes in these epithelial cells are primary contributors to the pathophysiology of Meniere's disease and endolymphatic hydrops, characterized by excessive fluid accumulation (NIH, 2022). Pharmacological interventions often target receptors and channels expressed on these cells, such as vasopressin V2 receptors or carbonic anhydrase, to modulate fluid balance (Journal of Otology, 2016). While not a single molecular target, these cells represent a crucial therapeutic site for treating vestibular and auditory disorders. They are also involved in the clearance of metabolic waste and cellular debris from the inner ear (Wikipedia, 2024). Research into these cells is vital for understanding the genetic basis of hearing loss, particularly in conditions like Pendred syndrome (UniProt, 2024).

Other names

Endolymphatic sac epitheliumES cellsSaccular epithelial cells

Pharmacological agents typically target specific proteins expressed on these cells, such as carbonic anhydrase, vasopressin V2 receptors, or ion transporters (e.g., pendrin), to modulate ion exchange and water permeability, thereby regulating endolymphatic volume and pressure.